Alternative splicing and disease

被引:389
|
作者
Tazi, Jamal [2 ]
Bakkour, Nadia [2 ]
Stamm, Stefan [1 ]
机构
[1] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA
[2] Univ Montpellier 2, Inst Mol Genet, CNRS, F-34095 Montpellier 5, France
关键词
Alternative splicing; Disease; Splicing code; Mutation; SPINAL MUSCULAR-ATROPHY; COLI APC GENE; STERIC-BLOCK OLIGONUCLEOTIDES; AMYOTROPHIC-LATERAL-SCLEROSIS; TISSUE-SPECIFIC EXPRESSION; RNA SECONDARY STRUCTURE; MESSENGER-RNA; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; TAU GENE;
D O I
10.1016/j.bbadis.2008.09.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Almost all protein-coding genes are spliced and their majority is alternatively spliced. Alternative splicing is a key element in eukaryotic gene expression that increases the coding capacity of the human genome and an increasing number of examples illustrates that the selection of wrong splice sites causes human disease. A fine-tuned balance of factors regulates splice site selection. Here, we discuss well-studied examples that show how a disturbance of this balance can cause human disease. The rapidly emerging knowledge of splicing regulation now allows the development of treatment options. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 26
页数:13
相关论文
共 50 条
  • [41] Alternative splicing:: multiple control mechanisms and involvement in human disease
    Cáceres, JF
    Kornblihtt, AR
    TRENDS IN GENETICS, 2002, 18 (04) : 186 - 193
  • [42] Alternative splicing in a presenilin 2 variant associated with Alzheimer disease
    Braggin, Jacquelyn E.
    Bucks, Stephanie A.
    Course, Meredith M.
    Smith, Carole L.
    Sopher, Bryce
    Osnis, Leah
    Shuey, Kiel D.
    Domoto-Reilly, Kimiko
    Caso, Christina
    Kinoshita, Chizuru
    Scherpelz, Kathryn P.
    Cross, Chloe
    Grabowski, Thomas
    Nik, Seyyed H. M.
    Newman, Morgan
    Garden, Gwenn A.
    Leverenz, James B.
    Tsuang, Debby
    Latimer, Caitlin
    Gonzalez-Cuyar, Luis F.
    Keene, Christopher Dirk
    Morrison, Richard S.
    Rhoads, Kristoffer
    Wijsman, Ellen M.
    Dorschner, Michael O.
    Lardelli, Michael
    Young, Jessica E.
    Valdmanis, Paul N.
    Bird, Thomas D.
    Jayadev, Suman
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (04): : 762 - 777
  • [43] Alternative RNA splicing of leucocyte tissue transglutaminase in coeliac disease
    Arbildi, P.
    Sonora, C.
    Del Rio, N.
    Marques, J. M.
    Hernandez, A.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2018, 87 (05)
  • [44] Alternative splicing and cell survival: from tissue homeostasis to disease
    Maria Paola Paronetto
    Ilaria Passacantilli
    Claudio Sette
    Cell Death & Differentiation, 2016, 23 : 1919 - 1929
  • [45] Alternative Splicing in Cardiovascular Disease-A Survey of Recent Findings
    Hasimbegovic, Ena
    Schweiger, Victor
    Kastner, Nina
    Spannbauer, Andreas
    Traxler, Denise
    Lukovic, Dominika
    Gyongyosi, Mariann
    Mester-Tonczar, Julia
    GENES, 2021, 12 (09)
  • [46] Regulation of plant disease resistance gene function by alternative splicing
    Zhang, X. -C.
    Kim, S. H.
    Gassmann, W.
    PHYTOPATHOLOGY, 2009, 99 (06) : S165 - S166
  • [47] GFAP Alternative Splicing and the Relevance for Disease - A Focus on Diffuse Gliomas
    van Asperen, Jessy, V
    Robe, Pierre A. J. T.
    Hol, Elly M.
    ASN NEURO, 2022, 14
  • [48] GFAP Alternative Splicing and the Relevance for Disease - A Focus on Diffuse Gliomas
    van Asperen, Jessy V.
    Robe, Pierre A. J. T.
    Hol, Elly M.
    ASN NEURO, 2022, 14 (01):
  • [49] Ontology Specific Alternative Splicing Changes in Alzheimer's Disease
    Lu, Yanjun
    Yue, Daoyuan
    Xie, Jiazhao
    Cheng, Liming
    Wang, Xiong
    FRONTIERS IN GENETICS, 2022, 13
  • [50] Combining genetic constraint with predictions of alternative splicing to prioritize deleterious splicing in rare disease studies
    Michael J. Cormier
    Brent S. Pedersen
    Pinar Bayrak-Toydemir
    Aaron R. Quinlan
    BMC Bioinformatics, 23